NASDAQ, LMNX - Luminex Corp
Luminex Corporation develops, manufactures and sells proprietary biological
testing technologies and products with applications throughout the life sciences
industry. The life sciences industry depends on a broad range of tests, called
bioassays, to perform diagnostic tests, discover and develop new drugs and
identify genes. Our xMAP? technology, an open architecture, multiplexing
technology, allows simultaneous analysis of up to 100 bioassays from a small
sample volume, typically a single drop of fluid, by reading biological tests on
the surface of microscopic polystyrene beads called microspheres. xMAP
technology combines this miniaturized liquid array bioassay capability with
small lasers, digital signal processors and proprietary software to create a
system offering advantages in speed, precision, flexibility and cost. ...
Read SEC Filing on NASDAQ.com »